"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A. Deshmukh said.

A new study has found that less than a quarter as many women under the age of 25 died of cervical cancer in the United States from 2019 to 2021 as died in an equivalent period from 1992 to 1994. The fall occurred for reasons besides the widespread adoption of the Gardasil and Cervarix vaccines against human papillomavirus (HPV),

A study from MUSC Hollings Cancer Center shows a 62% drop in cervical cancer deaths among women under 25, attributed to HPV vaccination. Despite this success, HPV vaccination rates remain below target,

This study found a steep decline in cervical cancer mortality among US women younger than 25 years between 2016 and 2021.

Cervical cancer deaths among women under 25 have significantly decreased, with researchers at the MUSC Hollings Cancer Center attributing this decline to the widespread use of the HPV vaccine. According to a recent study published in JAMA, cervical cancer mortality in this age group has dropped by 62% over the last decade.

A new study has revealed that cervical cancer deaths have strongly declined in the U.S. since 2016, likely due to increased rates of HPV vaccination.

Deaths from cervical cancer are plummeting among young women in the US, and scientists think we have a single vaccine to thank for the numerous lives saved. In the last decade alone, national health data suggests there has been a 62 percent drop in cervical cancer deaths in women under the age of 25.